← Leaderboards
Bart C De Jonghe
University Of Pennsylvania
$4,448,789
Attributed
$8,758,909
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,758,909 · 3
By mechanism
R01$8,758,909 · 3
Top collaborators
- Matthew R Hayes11 shared
- Robert P Doyle8 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Scott L Diamond$29,536,327
- Samantha Fortin$634,275
- David F Dinges$11,010,067
Others in their field
Other Emerging Leaders on “Vomiting”
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Olwen Hahn · Brigham And Women'S Hospital$13,576,315
- Cecile Feldman · Rbhs-School Of Dental Medicine$11,278,781
- Siyuan Ding · Stanford University$3,449,634
- David M Shade · Medical University Of South Carolina$3,023,208
- Anne-Marie Krachler · University Of Texas Hlth Sci Ctr Houston$2,985,930
Research focus
VomitingBody Weight DecreasedShrewsMalaiseNausea And VomitingPharmacotherapyRattusMediatingNauseaSiteObesityChronicNeuronsEmeticsCisplatinPharmaceutical PreparationsPhenotypeDiabetes MellitusCachexiaAnalogComplexAttenuatedBehaviorCell Nucleus
Grant awards (16)
Neural Mechanisms of Nausea, Vomiting, and Energy Dysregulation$639,550
R01 · FY2025 · DK · contact PI
Targeting the GDF15-GFRAL system to treat nausea and emesis$643,266
R01 · FY2024 · DK · contact PI
Neural Mechanisms of Nausea, Vomiting, and Energy Dysregulation$613,967
R01 · FY2024 · DK · contact PI
Second generation GLP-1 agonists without nausea/emesis side effects$569,065
R01 · FY2024 · DK
Targeting the GDF15-GFRAL system to treat nausea and emesis$670,069
R01 · FY2023 · DK · contact PI
Neural Mechanisms of Nausea, Vomiting, and Energy Dysregulation$639,550
R01 · FY2023 · DK · contact PI
Second generation GLP-1 agonists without nausea/emesis side effects$592,778
R01 · FY2023 · DK
Targeting the GDF15-GFRAL system to treat nausea and emesis$670,069
R01 · FY2022 · DK · contact PI
Second generation GLP-1 agonists without nausea/emesis side effects$592,778
R01 · FY2022 · DK
Targeting the GDF15-GFRAL system to treat nausea and emesis$683,819
R01 · FY2021 · DK · contact PI
Second generation GLP-1 agonists without nausea/emesis side effects$623,536
R01 · FY2021 · DK
Neural mechanisms of nausea, vomiting, and energy balance dysregulation in animal models$361,891
R01 · FY2021 · DK · contact PI
Neural mechanisms of nausea, vomiting, and energy balance dysregulation in animal models$361,901
R01 · FY2020 · DK · contact PI
Neural mechanisms of nausea, vomiting, and energy balance dysregulation in animal models$361,344
R01 · FY2019 · DK · contact PI
Neural mechanisms of nausea, vomiting, and energy balance dysregulation in animal models$360,928
R01 · FY2018 · DK · contact PI
Neural mechanisms of nausea, vomiting, and energy balance dysregulation in animal models$374,398
R01 · FY2017 · DK · contact PI